Viewing Study NCT03481660


Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2025-12-27 @ 11:44 PM
Study NCT ID: NCT03481660
Status: COMPLETED
Last Update Posted: 2025-01-07
First Post: 2018-03-19
Is NOT Gene Therapy: True
Has Adverse Events: True

Brief Title: A Study of the Efficacy and Safety of Brolucizumab vs. Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema
Sponsor:
Organization: